HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
Consolato M Sergi, Speaker at Pharma Conferences 2022
University of Ottawa, Canada
Title : Pathology and Patient Safety: The vital role of electronic medical record and pathology informatics in error reduction and precision medicine


Electronic medical record (EMR)'s use has increased exponentially worldwide. The traditional pen and paper way to record events and data in a patient's chart has evolved to EMR, allowing numerous opportunities. There is the potential to provide higher quality and safer care for patients while creating tangible augmentations for our organizations. EHRs provide accurate, modern, and complete information about patients at the point of care, enable quick access to patient records for optimally coordinated and efficient care, share data securely, and reduce medical errors by visualizing laboratory values retro- and prospectively. In addition, they allow a safer way to prescribe drugs, connect documents with streamlined coding and billing, and enable monitoring patient safety and productivity promptly. In the 21st century, pathology is entering a new era in healthcare. Pathology is already mobilizing new resources to face the challenges posed by the Institute of Medicine and Rand Corporation's call to action for patient safety. Implementing several modules targeting quality assurance (QA) parameters to monitor safety at pre-, analytical, and post-analytical levels is critical. The feasibility of implementing such a framework will have enormous consequences for healthcare in addressing system errors in the delivery of care. Pathology informatics can play a critical role in the prevention, identification, and correction of errors. Standardization of pathology reports, such as the College of American Pathologists (CAP) Checklist, has decreased the number of errors and misunderstandings concerning pathology findings useful for staging and therapy. Several vendors offer CAP cancer reporting checklists as part of their current laboratory information system (LIS) solutions. Virtual pathology lab data is soon handled along with imaging and pharmaceutical data in a single EMR, emphasizing the integration, versatility, and efficiency.


He the Chief of the Anatomic Pathology Division at the Children’s Hospital of Eastern Ontario, Professor of Pediatrics and Pathology, University of Alberta and Ottawa, Canada. He Canadian, born in Rome (Italy), obtained his MD degree with honors, qualification in Pediatrics and Pediatric Pathology Fellowship at the University of Genoa, Italy. He obtained his qualification in Pathology at the Ruprecht Karl University of Heidelberg, Germany, the Clinical Reader title at the University of Bristol, UK, PhD/Habilitation at the University of Innsbruck, Austria, MPH in Austria, and FRCPC (Pathology) from the Royal College of Physicians and Surgeons of Canada. In his research, he established his Canadian laboratory in August 2008. He welcomed more than 100 graduate MSc/Ph.D. students, fellows, undergraduate and summer students with on-going teaching in Genetics and Pathology. He is a Consultant of Carcinogenesis in Experimental Animals at the WHO/IARC, Lyon, France, and an “ad-hoc” Peer-Referee for the National Toxicology Program, NIH, USA. His areas of interest are Biology and Pathology of the Cardiovascular/Gastrointestinal System and Gut/Bile Microbiome as well as Bone Cell Biology. He has >300 peer-reviewed PubMed publications (h-index: 23, RG-score: 44.26, > 2,500 citations). He identified the role of apoptosis in the ductal plate malformation of the liver (Am J Pathol, 2000), a new CTL4/Neu1 gene fusion transcript in sialidosis (Hum Genet 2001, FEBS Lett 2002, J Med Genet 2003), two new genes, i.e., WDR62, which encodes a centrosome-associated protein (Nat Genet 2010) and OTX2, mutations of which contribute to dysgnathia (J Med Genet 2012), as well as characteristics of the bile microbiome (Infect Drug Resist 2019, HPB (Oxford) 2019, J Med Microbiol 2018, Eur J Clin Microbiol Infect Dis, 2018). He is editor in chief and in the editorial board of prestigious medical journals and international agencies.